Xiaflex collagenase clostridium histolyticum: Additional Phase III data

Additional data from the double-blind, U.S. Phase III CORD I trial in 306 patients showed that Xiaflex reduced the angle of both metacarpophalangeal (MP) and proximal interphalangeal (PIP) joint contr...